Literature DB >> 19017931

Cutting edge: the Idd3 genetic interval determines regulatory T cell function through CD11b+CD11c- APC.

Ana C Anderson1, Rucha Chandwaskar, David H Lee, Vijay K Kuchroo.   

Abstract

The Idd3 genetic interval confers protection against multiple autoimmune diseases, including type 1 diabetes and experimental autoimmune encephalomyelitis. The favored candidate gene in this interval is Il2, which is polymorphic between susceptible and resistant strains of mice. IL-2 regulates the growth/death of effector T cells as well as the generation/maintenance of regulatory T cells (Tregs), and recent studies have shown that NOD.Idd3 Tregs are more suppressive than their NOD counterparts. We have further dissected the mechanisms underlying the differential suppression by NOD and NODxIdd3 Tregs and find that it is determined by CD11b(+)CD11c(-) APCs. Thus, contrary to what might be expected, our data suggest that the differential suppressive activity of NOD and NODxIdd3 Tregs is not due to an effect of the Idd3 genetic interval on T cells but rather is due to differences in the APC compartment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017931      PMCID: PMC2614216          DOI: 10.4049/jimmunol.181.11.7449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Genetics of experimental autoimmune encephalomyelitis.

Authors:  J A Encinas; V K Kuchroo
Journal:  Curr Dir Autoimmun       Date:  1999

2.  Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming.

Authors:  Francesca Granucci; Sonia Feau; Véronique Angeli; François Trottein; Paola Ricciardi-Castagnoli
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

3.  Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping.

Authors:  P A Lyons; N Armitage; F Argentina; P Denny; N J Hill; C J Lord; M B Wilusz; L B Peterson; L S Wicker; J A Todd
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

4.  IL-2. A cofactor for induction of activated macrophage resistance to infection.

Authors:  M Belosevic; D S Finbloom; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

Review 5.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?

Authors:  P L Podolin; M B Wilusz; R M Cubbon; U Pajvani; C J Lord; J A Todd; L B Peterson; L S Wicker; P A Lyons
Journal:  Cytokine       Date:  2000-05       Impact factor: 3.861

7.  Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Authors:  Markus Feuerer; Wenyu Jiang; Phillip D Holler; Ansuman Satpathy; Christopher Campbell; Molly Bogue; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

8.  IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.

Authors:  Burkhard Becher; Brigit G Durell; Randolph J Noelle
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 9.  Tolerance, not immunity, crucially depends on IL-2.

Authors:  Thomas R Malek; Allison L Bayer
Journal:  Nat Rev Immunol       Date:  2004-09       Impact factor: 53.106

10.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

Authors:  M J Lenardo
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

View more
  13 in total

1.  A T cell extrinsic mechanism by which IL-2 dampens Th17 differentiation.

Authors:  Ana C Anderson; Jenna M Sullivan; Dewar J Tan; David H Lee; Vijay K Kuchroo
Journal:  J Autoimmun       Date:  2015-02-26       Impact factor: 7.094

2.  Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.

Authors:  Sue M Liu; David H Lee; Jenna M Sullivan; Denise Chung; Anneli Jäger; Bennett O V Shum; Nora E Sarvetnick; Ana C Anderson; Vijay K Kuchroo
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

3.  Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene.

Authors:  Heather I Fraser; Calliope A Dendrou; Barry Healy; Daniel B Rainbow; Sarah Howlett; Luc J Smink; Simon Gregory; Charles A Steward; John A Todd; Laurence B Peterson; Linda S Wicker
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

Review 4.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

5.  Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.

Authors:  Kevin S Goudy; Mark C Johnson; Alaina Garland; Chengwen Li; Richard J Samulski; Bo Wang; Roland Tisch
Journal:  Eur J Immunol       Date:  2011-04-20       Impact factor: 5.532

6.  EFFECT OF LIPOSOMAL CLODRONATE-DEPENDENT DEPLETION OF PROFESSIONAL ANTIGEN PRESENTING CELLS ON NUMBERS AND PHENOTYPE OF CANINE CD4+CD25+FOXP3+ REGULATORY T CELLS.

Authors:  Kriston F Weaver; John V Stokes; Sagen A Gunnoe; Joyce S Follows; Lydia Shafer; Mais G Ammari; Todd M Archer; John M Thomason; Andrew J Mackin; Lesya M Pinchuk
Journal:  J Vet Med Res       Date:  2014-06-09

7.  Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice.

Authors:  Emma E Hamilton-Williams; Xavier Martinez; Jan Clark; Sarah Howlett; Kara M Hunter; Daniel B Rainbow; Li Wen; Mark J Shlomchik; Jonathan D Katz; Georg F Beilhack; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

8.  Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.

Authors:  Cini R James; Irina Buckle; Franziska Muscate; Masayuki Otsuka; Mari Nakao; Jack Sh Oon; Raymond J Steptoe; Ranjeny Thomas; Emma E Hamilton-Williams
Journal:  Immunol Cell Biol       Date:  2016-01-14       Impact factor: 5.126

9.  Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.

Authors:  Martin J Richer; Danielle J Lavallée; Iryna Shanina; Marc S Horwitz
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Non-classical MHC I-E negatively regulates macrophage activation and Th17 cell development in NOD mice.

Authors:  Chunhui Yang; Nining Guo; Jinhua Liu; Juhao Yang; Kai Zhu; Hui Xiao; Qibin Leng
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.